• Latest
  • Trending
EU Drugs Regulator Approves Astrazeneca Covid-19 Vaccine

EU Drugs Regulator Approves Astrazeneca Covid-19 Vaccine

January 29, 2021
Nigerian Government Opens Portal for Covid Vaccination E-registration

Nigerian Government Opens Portal for Covid Vaccination E-registration

March 1, 2021

ARISE NEWSDAY

March 1, 2021
Former France President Sarkozy Found Guilty of Corruption, Sentenced to Prison

Former France President Sarkozy Found Guilty of Corruption, Sentenced to Prison

March 1, 2021

Global Business Report

March 1, 2021

Morning Show

March 1, 2021
Ramaphosa to Address South Africans on Covid 

South Africa Drops Coronavirus Alert Level After Dip in New Infections 

March 1, 2021
Nigeria, Kenya, 24 Other African Nations Set to Receive Covid Vaccines through COVAX

Nigeria, Kenya, 24 Other African Nations Set to Receive Covid Vaccines through COVAX

March 1, 2021
Germany Manufacturing PMI Revised Slightly Higher

Germany Manufacturing PMI Revised Slightly Higher

March 1, 2021
Ngozi Okonjo-Iweala Starts as WTO DG Today

Ngozi Okonjo-Iweala Starts as WTO DG Today

March 1, 2021
Dangote: Nigeria to Become Africa’s Largest Exporter of Cement, Fertilizer

Dangote: Nigeria to Save $2.5bn Annually from Petrochemical, Fertiliser Plants

March 1, 2021
As Fuel Queues Return, Nigeria’s State-owned Oil Company Cautions Against Panic Buying

As Fuel Queues Return, Nigeria’s State-owned Oil Company Cautions Against Panic Buying

March 1, 2021
Israel Ratifies Visa Exemption Agreement with UAE, the First with an Arab State

Netanyahu Says Iran ‘Clearly’ Behind Blast on Israeli-owned Ship

March 1, 2021
Katsina Schoolboys’ Kidnapping: Insecurity Prompts Nearby Zamfara State to Shut Schools 

Nigeria: Zamfara Governor Matawalle Insists on Negotiating with Bandits

March 1, 2021
Pope Prays for Abducted Zamfara Schoolgirls as Nigeria’s Military Intensifies Search

Pope Prays for Abducted Zamfara Schoolgirls as Nigeria’s Military Intensifies Search

March 1, 2021
Global Backlash Grows after Myanmar Forces Kill Two Protesters

Myanmar Protesters March Again Despite 18 Killed on Sunday

March 1, 2021
Trump to Address Major Meeting of Conservatives in First Post-White House Appearance

Trump Rules Out Forming New Political Party, Hints at Presidential Run in 2024

March 1, 2021
Liverpool End Run of Four League Defeats With Victory Over Sheffield United

Liverpool End Run of Four League Defeats With Victory Over Sheffield United

March 1, 2021
Chelsea 0-0 Man United: Blues Miss Top Four Chance With Goalless Draw

Chelsea 0-0 Man United: Blues Miss Top Four Chance With Goalless Draw

March 1, 2021
ARISE Newsnight

ARISE Newsnight

February 28, 2021
Dialogue with Bandits Very Relevant, Says Nigerian Governor

Zamfara Schoolgirls Yet to Be Rescued, Governor Matawalle Says

February 28, 2021
Nigeria’s Drug Agency Nabs Transborder Trafficker with Cocaine Worth $2.4m in Sokoto

Nigeria’s Drug Agency Nabs Transborder Trafficker with Cocaine Worth $2.4m in Sokoto

February 28, 2021
Leicester 1-3 Arsenal: Willian, Pepe Impress in Away Win 

Leicester 1-3 Arsenal: Willian, Pepe Impress in Away Win 

February 28, 2021
Is Sephora Making the Right Decision Expanding in 2021?

Is Sephora Making the Right Decision Expanding in 2021?

February 28, 2021
ARISE NEWSDAY

ARISE NEWSDAY

February 28, 2021
Morning Show

Morning Show

February 28, 2021
Two Reported Dead, Many Hurt as Myanmar Police Fire at Protesters

Two Reported Dead, Many Hurt as Myanmar Police Fire at Protesters

February 28, 2021
How Kagara Schoolboys, Others were Released

How Kagara Schoolboys, Others were Released

February 28, 2021
Popular Nigerian Music Producer Dr Frabz Reportedly Shot Dead in the US   

Popular Nigerian Music Producer Dr Frabz Reportedly Shot Dead in the US  

February 28, 2021

Released Kagara Schoolboys Went Through ‘Tremendous Torture’ in Captivity, Niger Governor Bello Says

February 28, 2021
Buhari ‘Disgusted’ By CNN, BBC Coverage of #EndSARS Protests

Buhari Tells Nigerian School Owners to Scale Up Security    

February 28, 2021
en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
No Result
View All Result
Monday, March 1, 2021
Arise News
  • HOME
  • Breaking
  • Global
  • Regional
  • BUSINESS
  • Politics
    • US ELECTION
  • Entertainment
  • Sports
  • TECH
  • Health
  • VIDEOS
  • Covid-19 Updates
Arise News
  • HOME
  • Breaking
  • Global
  • Regional
  • BUSINESS
  • Politics
    • US ELECTION
  • Entertainment
  • Sports
  • TECH
  • Health
  • VIDEOS
  • Covid-19 Updates
No Result
View All Result
Arise News
No Result
View All Result
Home Global

EU Drugs Regulator Approves Astrazeneca Covid-19 Vaccine

January 29, 2021
Reading Time: 5min
0 0
0
EU Drugs Regulator Approves Astrazeneca Covid-19 Vaccine
Share on FacebookShare on Twitter

European Union regulators have authorized AstraZeneca’s coronavirus vaccine for use in adults, amid criticism the bloc is not moving fast enough to vaccinate its population.

The European Medicines Agency licensed the vaccine to be used in people 18 and over, although concerns had been raised this week that not enough data exist to prove it works in older people.

The shot is the third Covid-19 vaccine given the greenlight by the European Medicines Agency, after ones made by Pfizer and Moderna. Both were authorized for all adults. The decision requires final approval from the European Commission, a process that occurred swiftly with the other vaccines.

“There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group,” the regulator said, but added that “protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines.

“EMA’s scientific experts considered that the vaccine can be used in older adults,” the agency said.

Many countries on the continent have been struggling to vaccinate people as quickly as Britain, Israel, the US and elsewhere, and it was long hoped that the AstraZeneca shot would help speed things up. On top of the recent news that the drugmaker would supply fewer doses in an initial batch, there were concerns that an age restriction would further hamper Europe’s vaccination program. Some doctors also feared restricting the vaccine’s use in older people might worsen the pandemic’s impact, since older people have suffered more severe disease and died at a higher rate from the coronavirus.

But in its decision Friday, the European agency said the AstraZeneca vaccine, developed with Oxford University, would be recommended for use in all adults.

While the AstraZeneca vaccine has been authorized for all adults in other countries, only 12% of the participants in its research were over 55 and they were enrolled later, so there hasn’t been enough time to get results.

In its decision on Friday, the EMA assessed four trials in the UK, Brazil and South Africa. The agency said the research showed the vaccine proved to be about 60% effective by reducing the number of people who got sick. The trials have not yet shown whether the vaccine can stop disease transmission.

The EU bet heavily on the AstraZeneca shot, which is cheaper and easier to handle than some other vaccines, with orders for 300 million doses to be delivered after authorization and options for another 100 million doses. It’s especially critical given the bloc’s difficulties rolling out vaccinations at a time when countries face surging cases in a pandemic that has taken the lives of more than 400,000 people in the 27-nation bloc.

While politicians have blamed supply problems for the slow rollout, other factors, like onerous paperwork and poor planning, have also played a role. The EU has particularly lashed out at AstraZeneca after the drugmaker said it would supply less vaccine in a first batch than originally anticipated. Further raising concerns about supplies to the bloc, which is home to some 450 million people, Moderna told countries including Italy and Denmark the company would be delivering fewer vaccines than originally expected.

Jens Spahn, the German health minister, said Friday he understood many were waiting impatiently for the vaccine, but cautioned that “several hard weeks of vaccine shortage still lie before us.”

On Thursday, a draft recommendation from Germany’s vaccination advisory committee said the AstraZeneca vaccine should only be given to people aged 18-64 for now.

Britain’s medicines regulatory agency also acknowledged the limited data in older people but still cleared the shot last month for all adults, with some caution for pregnant women.

The AstraZeneca shot is the third Covid-19 vaccine to be given the greenlight by the EMA, after ones made by Pfizer and Moderna. Those were authorized for all adults and trials showed they provided more protection, with roughly 95% efficacy rates.

Two more vaccine makers also recently announced results, with Novavax saying this week that its shot appears 89% effective based on early findings and Johnson & Johnson saying its long-awaited single-shot vaccine was 66% effective at preventing moderate to severe illness. If those vaccines are eventually licensed, that could help alleviate the pressure on the world’s huge demand for the limited shots currently available.

The authorization of the AstraZeneca vaccine comes amid a bitter dispute between the drugmaker and the bloc after the company said it would sharply reduce initial deliveries from 80 million doses to 31 million.

Amid fears doses from AstraZeneca could be diverted outside the bloc, EU officials are expected to propose measures Friday that could be used to block vaccine shipments to non-EU countries.

The AstraZeneca vaccine has already been authorized in several countries, including Britain, India, Argentina and Mexico. The World Health Organization is also reviewing it. A recommendation from the UN health agency would allow its purchase and distribution to developing countries from a global program known as COVAX.

Tags: Astrazeneca Covid-19
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2020 Arise News - Part of the Arise Media Group.

No Result
View All Result
  • HOME
  • Breaking
  • Global
  • Regional
  • BUSINESS
  • Politics
    • US ELECTION
  • Entertainment
  • Sports
  • TECH
  • Health
  • VIDEOS
  • Covid-19 Updates

© 2020 Arise News - Part of the Arise Media Group.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist